These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30729294)

  • 1. Management of clinically N0 neck in oropharyngeal carcinoma.
    Jouhi L; Atula T; Mäkitie A; Keski-Säntti H
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1205-1210. PubMed ID: 30729294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
    Abdel-Halim CN; O'Byrne TJ; Graves JP; Akpala CO; Moore EJ; Price DL; Tasche KT; Ma DJ; Neben-Wittich MA; Lester SC; Gamez M; Price KA; Bayne HEF; Rwigema JCM; Patel SH; McGee LA; Janus JR; Nagel TH; Hinni ML; Savvides PS; Van Abel KM; Routman DM
    Oral Oncol; 2023 Nov; 146():106569. PubMed ID: 37734203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.
    Suárez C; Barnes L; Silver CE; Rodrigo JP; Shah JP; Triantafyllou A; Rinaldo A; Cardesa A; Pitman KT; Kowalski LP; Robbins KT; Hellquist H; Medina JE; de Bree R; Takes RP; Coca-Pelaz A; Bradley PJ; Gnepp DR; Teymoortash A; Strojan P; Mendenhall WM; Eloy JA; Bishop JA; Devaney KO; Thompson LD; Hamoir M; Slootweg PJ; Vander Poorten V; Williams MD; Wenig BM; Skálová A; Ferlito A
    Auris Nasus Larynx; 2016 Oct; 43(5):477-84. PubMed ID: 27017314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.
    Böscke R; Cakir BD; Hoffmann AS; Wiegand S; Quetz J; Meyer JE
    Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):567-74. PubMed ID: 23661061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    Huo Z; Fu S; Ma C; Sheng S
    BMC Cancer; 2022 May; 22(1):535. PubMed ID: 35549914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.
    Lang P; Contreras J; Kalman N; Paterson C; Bahig H; Billfalk-Kelly A; Brennan S; Rock K; Read N; Venkatesan V; Sathya J; Mendez LC; MacNeil SD; Nichols AC; Fung K; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Theurer JA; Palma DA
    Radiat Oncol; 2020 Aug; 15(1):196. PubMed ID: 32795322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.
    Raman A; Sen N; Ritz E; Fidler MJ; Revenaugh P; Stenson K; Al-Khudari S
    Am J Otolaryngol; 2019; 40(5):626-630. PubMed ID: 31174931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level IIB lymph node metastasis in oropharyngeal squamous cell carcinoma.
    Gross BC; Olsen SM; Lewis JE; Kasperbauer JL; Moore EJ; Olsen KD; Price DL
    Laryngoscope; 2013 Nov; 123(11):2700-5. PubMed ID: 23686577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response evaluation of the neck in oropharyngeal cancer: Value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection.
    Lilja-Fischer JK; Jensen K; Eskildsen HW; Fink-Jensen V; Nielsen VE
    Acta Oncol; 2015; 54(9):1599-606. PubMed ID: 26198649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route.
    Panarese I; Aquino G; Ronchi A; Longo F; Montella M; Cozzolino I; Roccuzzo G; Colella G; Caraglia M; Franco R
    Expert Rev Anticancer Ther; 2019 Feb; 19(2):105-119. PubMed ID: 30582397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.
    Jouhi L; Atula T; Saarilahti K; Hagström J; Haglund C; Mohamed H; Mäkitie A; Keski-Säntti H
    Head Neck; 2017 Jul; 39(7):1412-1420. PubMed ID: 28464452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.